import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "where-to-buy-cjc-1295-dac-research-guide",
  title: "Where to Buy CJC-1295 with DAC: A Researcher's Sourcing Guide",
  description:
    "CJC-1295 with DAC (Drug Affinity Complex) is the long-acting GHRH analog studied for its extended half-life and pulsatile growth hormone release. This guide covers what to look for in a vendor, quality markers, storage requirements, and how DAC differs from CJC-1295 no-DAC for research purposes.",
  category: "Where to Buy",
  readMinutes: 9,
  publishedAt: "2026-06-07",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "CJC-1295 with DAC (also written CJC-1295 DAC, or simply 'CJC-1295' by some vendors) is a modified growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex addition that enables covalent binding to serum albumin in vivo. This modification extends the peptide's half-life from minutes (native GHRH1-29) to approximately 7–10 days in animal models, making it one of the longest-acting GHRH analogs available for research.",
    },
    {
      type: "heading",
      text: "CJC-1295 with DAC vs. CJC-1295 No-DAC: Critical Distinction",
    },
    {
      type: "paragraph",
      text: "The naming confusion between CJC-1295 with DAC and CJC-1295 without DAC (also called 'Modified GRF 1-29' or 'Mod GRF 1-29') is one of the most common sources of error in research peptide procurement. These are structurally and pharmacologically distinct compounds with fundamentally different half-lives and dosing considerations.",
    },
    {
      type: "table",
      headers: ["Feature", "CJC-1295 with DAC", "CJC-1295 No-DAC (Mod GRF 1-29)"],
      rows: [
        ["Half-life", "~7–10 days (in vivo, animal studies)", "~30 minutes"],
        ["Albumin binding", "Yes — covalent via maleimide-thiol reaction with Cys34", "No"],
        ["GH release pattern", "Sustained elevation ('GH bleed')", "Pulsatile, mimics natural GHRH rhythm"],
        ["Dosing frequency in studies", "Once or twice weekly", "Multiple times daily (with GHRP)"],
        ["Molecular weight", "~3647 Da", "~3367 Da"],
        ["CAS number", "863288-34-0", "863288-34-0 (often confused — verify with vendor)"],
        ["Common research application", "Sustained GH axis activation models", "Pulsatile GH research, combination with GHRP"],
      ],
    },
    {
      type: "callout",
      text: "Verification tip: When purchasing CJC-1295 with DAC, confirm the molecular weight on the COA is approximately 3647 Da. If the vendor lists 3367 Da, you may have received the no-DAC version. Mass spectrometry confirmation is the definitive method.",
    },
    {
      type: "heading",
      text: "What Research Uses CJC-1295 with DAC?",
    },
    {
      type: "paragraph",
      text: "CJC-1295 with DAC has been studied primarily in the context of growth hormone axis research, IGF-1 regulation, and body composition studies. Its extended half-life makes it useful for research designs that require sustained GHRH receptor activation without repeated dosing — particularly relevant in animal models where frequent injections are operationally difficult.",
    },
    {
      type: "subheading",
      text: "Published Research Areas",
    },
    {
      type: "list",
      items: [
        "Growth hormone secretion kinetics: The original Teichman et al. (2006) human pharmacology study demonstrated dose-dependent increases in GH AUC and IGF-1 lasting 14+ days after a single injection",
        "IGF-1 upregulation: Sustained GH elevation via DAC creates prolonged IGF-1 responses — useful for studying downstream anabolic and metabolic effects of sustained GH axis activation",
        "Body composition research: Studies using CJC-1295 DAC in combination with GHRPs (GHRP-6, Ipamorelin) examine lean mass accretion and fat mobilization under sustained GH axis stimulation",
        "Anti-aging and longevity models: Sustained GH/IGF-1 enhancement is studied in aged animal models for effects on muscle mass, bone density, and metabolic parameters",
        "Comparison studies: CJC-1295 DAC vs. no-DAC comparison studies test whether pulsatile vs. sustained GH release produces different physiological outcomes",
      ],
    },
    {
      type: "heading",
      text: "Quality Markers: What to Look For When Buying CJC-1295 DAC",
    },
    {
      type: "paragraph",
      text: "CJC-1295 with DAC is a more complex peptide to synthesize and verify than many common research peptides. The maleimide DAC modification must be correctly attached and not hydrolyzed during synthesis or storage. This adds quality control complexity that researchers should account for in vendor selection.",
    },
    {
      type: "subheading",
      text: "Essential COA Elements",
    },
    {
      type: "list",
      items: [
        "HPLC purity: ≥98% is the minimum acceptable threshold for research grade; ≥99% preferred. Request the actual chromatogram — a single number without a supporting chart is insufficient",
        "Mass spectrometry (MS) confirmation: The MS report should show a molecular ion peak consistent with CJC-1295 DAC (~3647 Da). This confirms correct synthesis including the DAC moiety",
        "Endotoxin/LAL testing: Important if any in vivo research is planned — lipopolysaccharide contamination can confound GH/IGF-1 measurements by triggering inflammatory responses",
        "Amino acid analysis or peptide sequencing: Confirms correct primary sequence beyond MW verification",
        "Batch-specific COA: Each production lot should have its own COA — a generic COA used across batches is a red flag",
      ],
    },
    {
      type: "heading",
      text: "Storage Requirements for CJC-1295 DAC",
    },
    {
      type: "paragraph",
      text: "CJC-1295 with DAC has specific stability characteristics that researchers must account for both during shipping and in the laboratory. The DAC maleimide moiety is particularly susceptible to hydrolysis under aqueous conditions at elevated temperatures.",
    },
    {
      type: "subheading",
      text: "Lyophilized (Dry Powder) Storage",
    },
    {
      type: "list",
      items: [
        "Long-term storage: -20°C in sealed vial, protected from light and humidity",
        "Acceptable short-term: 4°C refrigeration for periods up to 4 weeks if vial integrity is maintained",
        "Room temperature tolerance: Limited — lyophilized CJC-1295 DAC should not be stored at room temperature for extended periods",
        "Avoid freeze-thaw cycles of reconstituted solution — lyophilize in single-use aliquots when possible",
      ],
    },
    {
      type: "subheading",
      text: "Reconstituted Solution Storage",
    },
    {
      type: "list",
      items: [
        "Reconstitute with bacteriostatic water (0.9% benzyl alcohol in sterile water) for extended shelf life",
        "Refrigerate at 2–8°C after reconstitution",
        "Use within 4 weeks of reconstitution — the DAC moiety degrades more rapidly in solution than lyophilized",
        "Do not use acetic acid as reconstitution solvent — this can affect DAC stability; bacteriostatic water or sterile saline preferred",
      ],
    },
    {
      type: "heading",
      text: "Shipping Considerations",
    },
    {
      type: "paragraph",
      text: "CJC-1295 DAC is shipped as lyophilized powder by reputable vendors. The lyophilized form is relatively tolerant of short-term temperature excursions, but researchers ordering internationally should be aware of extended transit times and customs clearance delays that may expose shipments to temperature extremes.",
    },
    {
      type: "list",
      items: [
        "Request insulated packaging with desiccant for international orders — particularly important in summer months",
        "Verify the vendor's shipping timeline and whether cold packs are included for your region",
        "Inspect the vial seal on receipt — any evidence of compromised lyophilization (clumping, discoloration, moisture inside vial) warrants contacting the vendor before use",
        "When in doubt about post-shipping integrity, an HPLC check at a reference lab is the definitive quality confirmation",
      ],
    },
    {
      type: "heading",
      text: "What Makes a Reliable CJC-1295 DAC Vendor",
    },
    {
      type: "paragraph",
      text: "The research peptide vendor landscape includes a wide range of quality tiers. For a complex modification like the DAC peptide, the quality gap between top-tier and lower-tier vendors is particularly consequential — a hydrolyzed or incorrectly synthesized DAC modification produces a peptide that may be indistinguishable visually but lacks the albumin-binding property that defines CJC-1295 DAC's pharmacological profile.",
    },
    {
      type: "subheading",
      text: "Vendor Evaluation Criteria",
    },
    {
      type: "list",
      items: [
        "Third-party testing: COAs should reference an independent analytical laboratory — in-house testing without third-party verification is a quality flag",
        "Full COA on request: Any vendor that cannot provide a batch-specific HPLC + MS COA on request should be excluded from consideration for DAC peptides",
        "Synthesis method transparency: Reputable vendors will indicate whether synthesis is performed by a GMP-certified or ISO-certified peptide manufacturer",
        "Reorder consistency: For longitudinal research, the vendor must demonstrate batch-to-batch consistency — ask for comparative COAs across multiple batches",
        "Customer service and regulatory awareness: A vendor that understands research-use positioning and maintains appropriate disclaimers demonstrates professionalism consistent with legitimate research supply",
      ],
    },
    {
      type: "heading",
      text: "Common Research Combinations with CJC-1295 DAC",
    },
    {
      type: "paragraph",
      text: "CJC-1295 DAC is most commonly studied in combination with a growth hormone-releasing peptide (GHRP) to achieve both GHRH and ghrelin receptor activation simultaneously. The most frequently paired compounds in the literature include:",
    },
    {
      type: "list",
      items: [
        "CJC-1295 DAC + Ipamorelin: The most popular combination in body composition research — DAC provides sustained GHRH effect, Ipamorelin provides pulsatile GHRP effect without cortisol/prolactin elevation",
        "CJC-1295 DAC + GHRP-6: Historical pairing with higher GH output but including the appetite-stimulant and cortisol-elevating effects of GHRP-6",
        "CJC-1295 DAC + GHRP-2: Higher GH output than Ipamorelin combination, with modest cortisol elevation",
        "CJC-1295 DAC alone: Used in studies isolating the contribution of sustained GHRH-axis activation without additional ghrelin signaling",
      ],
    },
    {
      type: "heading",
      text: "Regulatory Status",
    },
    {
      type: "paragraph",
      text: "CJC-1295 with DAC has no approved pharmaceutical equivalent in any jurisdiction and is not an FDA-approved drug. It is classified as a research chemical in the United States and most other countries. WADA includes GHRH analogs on its Prohibited List — researchers working with athletic populations should be aware of this classification.",
    },
    {
      type: "divider",
    },
    {
      type: "disclaimer",
      text: "This article is for informational purposes only and is intended for researchers studying GHRH analog pharmacology in appropriate research settings. CJC-1295 with DAC is not approved for human therapeutic use. Always verify current regulatory status in your jurisdiction before procuring research compounds.",
    },
  ],
};
